Should prolactin be reconsidered as a therapeutic target in human breast cancer?

This publication has 58 references indexed in Scilit:

• Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
  Endocrine Reviews, 1998
• Development of Recombinant Human Prolactin Receptor Antagonists by Molecular Mimicry of the Phosphorylated Hormone
  Endocrinology, 1998
• Prolactin as an Autocrine/Paracrine Factor in Breast Tissue
  Journal of Mammary Gland Biology and Neoplasia, 1997
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo
  Journal of Biological Chemistry, 1995
• Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin.
  Proceedings of the National Academy of Sciences, 1995
• Characterization of an up-stream promoter directing extrapituitary expression of the human prolactin gene
  Molecular Endocrinology, 1994
• The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
  Endocrinology, 1993
• Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase
  Cell, 1993
• A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells
  Endocrinology, 1992
• Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family
  Cell, 1988